Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Revenue (2023 - 2025)

Upstream Bio has reported Revenue over the past 3 years, most recently at $668000.0 for Q4 2025.

  • Quarterly results put Revenue at $668000.0 for Q4 2025, up 8.97% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (up 20.42% YoY), and the annual figure for FY2025 was $2.9 million, up 20.42%.
  • Revenue for Q4 2025 was $668000.0 at Upstream Bio, down from $683000.0 in the prior quarter.
  • Over the last five years, Revenue for UPB hit a ceiling of $937000.0 in Q2 2025 and a floor of $450000.0 in Q4 2023.
  • Median Revenue over the past 3 years was $617000.0 (2023), compared with a mean of $629500.0.
  • Peak annual rise in Revenue hit 83.73% in 2025, while the deepest fall reached 11.56% in 2025.
  • Upstream Bio's Revenue stood at $450000.0 in 2023, then skyrocketed by 36.22% to $613000.0 in 2024, then increased by 8.97% to $668000.0 in 2025.
  • The last three reported values for Revenue were $668000.0 (Q4 2025), $683000.0 (Q3 2025), and $937000.0 (Q2 2025) per Business Quant data.